Krispy Kreme, Inc. (DNUT)
NASDAQConsumer StaplesGrocery StoresSnapshot 2026-09-04
$3.38+1.20%
Close 2026-09-04 · 1-day change
NASDAQConsumer StaplesGrocery StoresSnapshot 2026-09-04
Warn: Management is running behind on a stated commitment.
Krispy Kreme aims for revenue between $1.25B and $1.35B in 2026. Free cash flow target is above $15M. New products and market expansion support growth. Leadership buying stock shows confidence.
The company is loss-making with negative free cash flow yield. Recent earnings misses and legal issues hurt reputation. Analysts expect about 10% revenue decline next year.
The market expects about 10% revenue decline and negative growth over 3-5 years. Our fair value aligns with this cautious outlook, reflecting the turnaround risks.
Breaks if: Capital expenditures exceed $60M or fall below $50M in FY26
Continue disciplined capital spending with guidance of $50 million to $60 million in capital expenditures for fiscal 2026.
This is not a price target or investment advice.
A long-form read on the 1–3 year hold thesis. It updates when the weekly evidence changes.
This investment represents a turnaround story in the Consumer Staples sector. The current thesis state is cautious, given the company's recent financial struggles and elevated risks.
The market appears to have priced in a low expectations gap, suggesting that DNUT is seen as relatively cheap compared to its peers. However, the valuation reflects a justified stance given the company's recent performance and ongoing losses.
Fundamentals may remain under pressure due to recent earnings misses and a neutral management outlook. The company has set ambitious revenue and cash flow targets for 2026, but achieving these goals will be crucial for improving its financial standing.
The long-term thesis hinges on management's ability to meet its revenue and cash flow targets, as well as external factors like inflation trends and the performance of sector peers. A cut in guidance could lead to a significant negative reaction from the market.
The most important moves since the prior daily snapshot.
Mixed, the news cuts both ways. The latest earnings beat supports the revenue target for 2026. However, pre-tax losses at the Irish arm may hinder profitability objectives.
as of 2026-09-04
Review the evidence to watch, what would become a concern, and what would make it less concerning.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Stated as a priority in 2 of last 2 quarters. Capital expenditures were $16.1 million in first half 2026, down 70% from $54.1 million in first half 2025. The Company maintains 2026 guidance of $50M to $60M capex, reflecting disciplined spending and delivery consistent with stated priorities.
“Capital expenditures of $50 million to $60 million.”
“Capital expenditures of $50 million to $60 million.”
Breaks if: Free cash flow falls below $15M in FY26
Target free cash flow exceeding $15 million for fiscal year 2026, reflecting improved cash generation.
Stated as a priority in 2 of last 2 quarters. Year-to-date free cash flow was negative $6.1 million in first half 2026, improving $101.3 million versus first half 2025. The Company maintains guidance for free cash flow exceeding $15 million in 2026, showing progress but not yet fully delivering the target.
“Free cash flow of more than $15 million.”
“Free cash flow of more than $15 million (updated).”
Breaks if: Restructuring fails or new products do not improve revenue
Breaks if: Revenue falls below $1.25B in FY26
In the next 1 to 3 years, DNUT's performance will depend on its execution against targets and the broader economic environment. Not investment advice.